Growth hormone prescribing and initial BMI SDS: Increased biochemical adverse effects and costs in obese children without additional gain in height

BACKGROUND: Recombinant human growth hormone (rhGH) treatment in children is usually prescribed using actual body weight. This may result in inappropriately high doses in obese children. METHODS: Retrospective audit of all paediatric patients treated with rhGH 2010–14 at a tertiary paediatric hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawcutt, Daniel B., Bellis, Jennifer, Price, Victoria, Povall, Anne, Newland, Paul, Richardson, Paul, Peak, Matthew, Blair, Jo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513545/
https://www.ncbi.nlm.nih.gov/pubmed/28715498
http://dx.doi.org/10.1371/journal.pone.0181567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513545/
https://www.ncbi.nlm.nih.gov/pubmed/28715498
http://dx.doi.org/10.1371/journal.pone.0181567

Ejemplares similares